Authors
Kenta Murakami, Shin Hasegawa, Akinao Miki, Hirotaka Yamauchi, Akimitsu Tanaka, Takeki Ohashi, Soh Hosoba
Published in
Interdisciplinary cardiovascular and thoracic surgery. Oct 22, 2025. Epub Oct 22, 2025.
Abstract
The mortality rate of ventricular septal defect (VSD) following acute myocardial infarction remains high. Mechanical circulatory support devices have been shown to facilitate delayed surgery and improve postoperative survival, although clear guidelines for device selection are lacking.
This study presents a retrospective cohort analysis of 18 patients with post-infarction VSD treated with microaxial flow pump (mAFP) from March 2017 to November 2024. Patients were divided into two groups: the Percutaneous group utilized Impella 2.5 or CP (Abiomed, Danvers, MA, USA) and the Axillary access group (Impella 5.0 or 5.5). Their clinical outcomes and early to midterm survival rates were analyzed.
The survival discharge rate was 31% (4 in 13 patients) in the Percutaneous group and 100% (5 patients) in the Axillary access group, with a significant difference (p = 0.029). 7 patients who were initially managed with percutaneous mAFP and later required the addition of extracorporeal membrane oxygenation all died perioperatively. The 100-day Kaplan-Meier analysis showed a significant improvement in survival rates in the Axillary access group compared to the Percutaneous group. (Log-rank, p = 0.020).
These findings illustrate variation in surgical timing and device selection, and suggest that the early use of an axillary-access mAFP may warrant further investigation in post-myocardial infarction VSD patients.
PMID:
41124610
Bibliographic data and abstract were imported from PubMed on 23 Oct 2025.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 55
- Comments 0